InsidersTradesSigma
크레버스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 크레버스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 크레버스 has published 2 public disclosures. Market capitalisation: €70.1bn. The latest transaction was reported on 5 June 2026 (Other). Among the most active insiders: 크레버스. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,739 of 27,989 companies
77.6
score / 100
Value92
Quality64
FCF yld21%
Earn yld9.4%
EV/EBITDA3.7x
ROE·
Gross mgn100%
Net mgn3.0%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 June 2026
About 크레버스
크레버스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.